InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-29.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Solomons Neil, Directeur Médical. Insider active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 11 filings have been published. Split: 0 buy · 6 sells. Total volume traded: €4m. Activity tracked since 9 August 2021. The latest transaction was filed on 2 March 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
8,500 shares0Common StockSEC:0001628280-22-005119:0
50,000 shares@ US$30.1725.1% of flowCommon SharesSEC:0001628280-21-023153
50,000 shares@ US$30.170.062% mcap25.1% of flowCommon SharesSEC:0001628280-21-023153:0
45,000 shares@ US$5.304.0% of flowCommon StockSEC:0001628280-21-021484
45,000 shares@ US$5.300.0098% mcap4.0% of flowCommon StockSEC:0001628280-21-021484:0
150,000 shares@ US$3.207.8% of flowCommon SharesSEC:0001628280-21-018594
150,000 shares@ US$3.200.019% mcap7.8% of flowCommon SharesSEC:0001628280-21-018594:0
5,000 shares@ US$15.850.0032% mcap1.3% of flowCommon StockSEC:0001628280-21-017662:0
5,000 shares@ US$15.851.3% of flowCommon StockSEC:0001628280-21-017662
45,000 shares@ US$16.030.029% mcap11.8% of flowCommon StockSEC:0001628280-21-016407:0
45,000 shares@ US$16.0311.8% of flowCommon StockSEC:0001628280-21-016407
11 of 11 declarations
About Solomons Neil
Neil Solomons is the Chief Medical Officer at Aurinia Pharmaceuticals Inc. He oversees the company's clinical and research initiatives, ensuring innovation in the field of pharmaceuticals. His medical expertise is essential for the development of new therapies.
